Skip to content
GenoLensGenoLens

PGM1

Chr 1p31.3

phosphoglucomutase 1

MANE:
ENST00000371084.8

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Acute rhabdomyolysis

    BIALLELIC, autosomal or pseudoautosomal
  • Clefting

    BIALLELIC, autosomal or pseudoautosomal
  • Congenital disorders of glycosylation

    BIALLELIC, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Glycogen storage disease

    BIALLELIC, autosomal or pseudoautosomal
  • Ketotic hypoglycaemia

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal

+4 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • PGM1-congenital disorder of glycosylation

    0.84
  • ALG13-CDG

    0.55
  • developmental and epileptic encephalopathy, 36

    0.55
  • MPDU1-congenital disorder of glycosylation

    0.55
  • RFT1-congenital disorder of glycosylation

    0.55
  • disorder of glycogen metabolism

    0.51
  • Glycogen storage disease due to glycogenin deficiency

    0.51
  • Glycogen storage disease due to phosphoglucomutase deficiency

    0.50
  • congenital disorder of deglycosylation 1

    0.50
  • Alacrimia-choreoathetosis-liver dysfunction syndrome

    0.50

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Phosphoglucomutase-1

Catalyzes the reversible isomerization of alpha-D-glucose 1-phosphate to alpha-D-glucose 6-phosphate (PubMed:15378030, PubMed:25288802). The mechanism proceeds via the intermediate compound alpha-D-glucose 1,6-bisphosphate (Probable) (PubMed:25288802). This enzyme participates in both the breakdown and synthesis of glucose (PubMed:17924679, PubMed:25288802)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.